Medical Devices

New filter will improve speed, safety and economics of biopharma manufacturing

Published in Hepatitis Weekly, January 10th, 2005

The introduction of the new Ultipor VF UDV20 virus filter by Pall Corporation (NYSE: PLL) will significantly improve the speed, safety and economics of biopharmaceutical manufacturing.

By combining Pall's proven Ultipor VF DV20 membrane with its high area Ultipleat cartridge, the new UDV20 virus filter offers up to six square meters (6m²) of surface area in a single filter cartridge. The new design doubles the surface area of the original Ultipor VF DV20 virus filter and does the work of two or more filters without increasing the footprint, complexity or cost of the filter system.

The combination of Ultipleat filter construction with the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2005-01-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry